Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
6.18M
-
Shares change
-
-278K
-
Total reported value, excl. options
-
$19.2M
-
Value change
-
-$903K
-
Put/Call ratio
-
3.11
-
Number of buys
-
8
-
Number of sells
-
-22
-
Price
-
$3.10
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q3 2021
48 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q3 2021.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.18M shares
of 108M outstanding shares and own 5.75% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (3.04M shares), MORGAN STANLEY (582K shares), BlackRock Inc. (537K shares), VANGUARD GROUP INC (512K shares), GEODE CAPITAL MANAGEMENT, LLC (271K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (266K shares), Ergoteles LLC (134K shares), RENAISSANCE TECHNOLOGIES LLC (129K shares), STATE STREET CORP (105K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (70.6K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.